The result was corroborated in a second validation cohort of n > 196 mixed stage patients (IST cohort) (Supplementary Fig. 1b), supporting an inverse relationship between CHST11 expression and AR signaling in prostate cancer. This evidence concerns the gene AR and prostate cancer.